• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.肾功能不全患者多黏菌素B的药代动力学：一例报告
Clin Infect Dis. 2011 May;52(10):1280-1. doi: 10.1093/cid/cir137.
2
Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.肾功能不全患者多粘菌素B的给药剂量与药代动力学
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01337-16. Print 2017 Jan.
3
Polymyxin B and haemofiltration in an adolescent with leukaemia.一名青少年白血病患者使用多黏菌素B及血液滤过治疗
J Antimicrob Chemother. 2014 May;69(5):1434. doi: 10.1093/jac/dkt522. Epub 2014 Jan 8.
4
Polymyxin B dosing in obese and underweight adults.肥胖及体重过轻成年人的多黏菌素B给药剂量
Clin Infect Dis. 2013 Dec;57(12):1785. doi: 10.1093/cid/cit604. Epub 2013 Sep 18.
5
Population Pharmacokinetics of Polymyxin B.多黏菌素 B 的群体药代动力学。
Clin Pharmacol Ther. 2018 Sep;104(3):534-538. doi: 10.1002/cpt.981. Epub 2018 Jan 8.
6
Reply to Pai.回复派伊。
Clin Infect Dis. 2013 Dec;57(12):1786. doi: 10.1093/cid/cit608. Epub 2013 Sep 18.
7
Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis.多黏菌素 B 在持续静脉-静脉血液透析患者中的药代动力学。
J Antimicrob Chemother. 2013 Mar;68(3):674-7. doi: 10.1093/jac/dks437. Epub 2012 Nov 23.
8
Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia.婴儿多药耐药肺炎克雷伯菌菌血症患者多黏菌素 B 的药代动力学。
Pediatr Infect Dis J. 2011 Jun;30(6):537-9. doi: 10.1097/INF.0b013e318207a7c1.
9
Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.重症患者静脉注射多黏菌素 B 的群体药代动力学：剂量方案选择的意义。
Clin Infect Dis. 2013 Aug;57(4):524-31. doi: 10.1093/cid/cit334. Epub 2013 May 22.
10
How can polymyxin B be dosed based on current pharmacokinetic knowledge?基于当前的药代动力学知识，多粘菌素B应如何给药？
Eur J Clin Pharmacol. 2024 Sep;80(9):1421-1423. doi: 10.1007/s00228-024-03708-3. Epub 2024 Jun 7.

引用本文的文献

1
Biomarker-Driven Pharmacokinetics and Efficacy of Polymyxin B in Critically Ill Patients with XDR-GN Pneumonia.生物标志物驱动的多黏菌素B在XDR-GN肺炎重症患者中的药代动力学及疗效
Pharmaceuticals (Basel). 2025 Apr 17;18(4):586. doi: 10.3390/ph18040586.
2
Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road.下一代多粘菌素类抗生素：照亮黑暗之路的一线希望
Antibiotics (Basel). 2022 Nov 27;11(12):1711. doi: 10.3390/antibiotics11121711.
3
Polymyxin B in Patients With Renal Impairment: Is It Necessary to Adjust Dose?肾功能损害患者使用多粘菌素B：是否需要调整剂量？
Front Pharmacol. 2022 Jun 28;13:955633. doi: 10.3389/fphar.2022.955633. eCollection 2022.
4
Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy.硫酸黏菌素在重症患者中的群体药代动力学：暴露量与临床疗效
Front Pharmacol. 2022 Jun 16;13:915958. doi: 10.3389/fphar.2022.915958. eCollection 2022.
5
Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients.肾移植患者多黏菌素B的群体药代动力学及剂量优化
Front Pharmacol. 2021 Aug 25;12:727170. doi: 10.3389/fphar.2021.727170. eCollection 2021.
6
Rescuing the Last-Line Polymyxins: Achievements and Challenges.拯救最后一线多黏菌素：成就与挑战。
Pharmacol Rev. 2021 Apr;73(2):679-728. doi: 10.1124/pharmrev.120.000020.
7
A Review of the Clinical Pharmacokinetics of Polymyxin B.多粘菌素B的临床药代动力学综述
Antibiotics (Basel). 2019 Mar 22;8(1):31. doi: 10.3390/antibiotics8010031.
8
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity.多粘菌素所致急性肾损伤：给药及其他降低毒性的策略
Antibiotics (Basel). 2019 Mar 14;8(1):24. doi: 10.3390/antibiotics8010024.
9
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).多黏菌素优化使用国际共识指南：获得美国临床药师协会（ACCP）、欧洲临床微生物学和传染病学会（ESCMID）、美国感染病学会（IDSA）、国际抗感染药理学会（ISAP）、重症医学学会（SCCM）和感染病药师学会（SIDP）认可。
Pharmacotherapy. 2019 Jan;39(1):10-39. doi: 10.1002/phar.2209.
10
Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples.静脉注射多粘菌素 B 的群体药代动力学：来自临床样本的数据。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01493-17. Print 2018 Mar.

本文引用的文献

1
Variability of polymyxin B major components in commercial formulations.市售制剂中多粘菌素B主要成分的变异性。
Int J Antimicrob Agents. 2010 Mar;35(3):308-10. doi: 10.1016/j.ijantimicag.2009.11.005. Epub 2009 Dec 31.
2
Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma.评论：人血浆中多粘菌素B的反相高效液相色谱测定法的开发与验证
J Antimicrob Chemother. 2009 Mar;63(3):627-8; author reply 628-9. doi: 10.1093/jac/dkn483. Epub 2008 Nov 19.
3
Pharmacokinetics of intravenous polymyxin B in critically ill patients.危重患者静脉注射多粘菌素B的药代动力学
Clin Infect Dis. 2008 Nov 15;47(10):1298-304. doi: 10.1086/592577.
4
Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections.多粘菌素B1在多重耐药革兰氏阴性菌感染患者中的药代动力学
Diagn Microbiol Infect Dis. 2008 Feb;60(2):163-7. doi: 10.1016/j.diagmicrobio.2007.08.008. Epub 2007 Oct 4.
5
Polymyxin B: similarities to and differences from colistin (polymyxin E).多黏菌素B：与黏菌素（多黏菌素E）的异同
Expert Rev Anti Infect Ther. 2007 Oct;5(5):811-21. doi: 10.1586/14787210.5.5.811.
6
Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.硫酸多粘菌素B和粘菌素：用于应对新出现的多重耐药革兰氏阴性菌的老抗生素。
Ann Pharmacother. 1999 Sep;33(9):960-7. doi: 10.1345/aph.18426.

Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.

作者信息

Kwa Andrea L H, Abdelraouf Kamilia, Low Jenny G H, Tam Vincent H

出版信息

Clin Infect Dis. 2011 May;52(10):1280-1. doi: 10.1093/cid/cir137.

DOI:10.1093/cid/cir137
PMID:21507928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3115279/
Abstract
摘要